Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 2, 2010, Pages 298-304

  Cong, Hongliang ^a   Li, Ximing ^a   Ma, Lijun ^a   Jiang, Hua ^a   Mao, Yongmin ^a   Xu, Meilin ^a  

^a TIANJIN CHEST HOSPITAL   (China)

Author keywords

ACE; ACEI; AF; angiotensin II receptor type 1; angiotensin II receptor type 2; angiotensin receptor blocker; angiotensin converting enzyme; angiotensin converting enzyme inhibitor; ARB; AT1 R; AT2 R; atrial fibrillation; GAPDH; glyceraldehyde 3 phosphate dehydrogenase; LA; left atrium; PBS; PCR; phosphate buffered saline; polymerase chain reaction; RA; RAS; renin angiotensin system; reverse transcription polymerase chain reaction; right atrium; RT PCR; sinus rhythm; SR

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR 1; ANGIOTENSIN RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ATRIUM; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MITRAL VALVE DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATIC HEART DISEASE; RNA TRANSCRIPTION; SINUS RHYTHM;

ADULT; ATRIAL FIBRILLATION; BIOPSY; BLOTTING, WESTERN; FEMALE; HEART ATRIA; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHEUMATIC HEART DISEASE; RNA, MESSENGER; UP-REGULATION;

EID: 77955468795     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.10.035     Document Type: Article

References (23)

1. A. Goette, M. Arndt, C. Röcken, A. Spiess, T. Staack, and J.C. Geller et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans Circulation 101 2000 2678 2681
2. A. Boldt, U. Wetzel, J. Weigl, J. Garbade, J. Lauschke, and G. Hindricks et al. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease J Am Coll Cardiol 42 2003 1785 1792
3. M.C.E.F. Wijffels, C.J.H.J. Kirchhof, R. Dorland, and M.A. Allessie Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1995 1954 1968
4. E.P. Anyukhovsky, E.A. Sosunov, P. Chandra, T.S. Rosen, P.A. Boyden, and P. Danilo et al. Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation Cardiovasc Res 66 2005 353 363
5. S.V. Pandit, O. Berenfeld, J.M.B. Anumonwo, R.M. Zaritski, J. Kneller, and A. Nattel et al. Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation Biophys J 88 2005 3806 3821
6. A. Goette, P. Hoffmanns, W. Enayati, U. Meltendorf, J.C. Geller, and H.U. Klein Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation Am J Cardiol 88 2001 906 909
7. A. Goett, T. Staack, C. Röcken, M. Arndt, J.C. Geller, and C. Huth et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation J Am Coll Cardiol 35 2000 1669 1677
8. P.H. Sugden, and A. Clerk Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors Cell Signal 9 1997 337 351
9. M. van Eickels, C. Grohé, K. Löbbert, M. Stimpel, and H. Vetter Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts Naunyn Schmiedebergs Arch Pharmacol 359 1999 394 399
10. A. Goette, G. Juenemann, B. Peters, H.U. Klein, A. Roessner, and C. Huth et al. Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery Cardiovasc Res 54 2002 390 396
11. K. Sakabe, N. Fukuda, T. Nada, H. Shinohara, Y. Tamura, and T. Wakatsuki Age-related changes in the electrophysiologic properties of the atrium in patients with no history of atrial fibrillation Jpn Heart J 44 2003 385 393
12. K.-C. Ueng, T.-P. Tsai, W.-C. Yu, C.-F. Tsai, M.-C. Lin, and Chan K-C. et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation: results of a prospective and controlled study Eur Heart J 24 2003 2090 2098
13. A.H. Madrid, M.G. Bueno, J.M.G. Rebollo, I. Marín, G. Peña, and E. Bernal et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study Circulation 106 2002 331 336
14. K. Wachtell, M. Lehto, E. Gerdts, M.H. Olsen, B. Hornestam, and B. Dahlöf et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study J Am Coll Cardiol 45 2005 712 719
15. K. Wachtell, B. Hornestam, M. Lehto, D.J. Slotwiner, E. Gerdts, and M.H. Olsen et al. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study J Am Coll Cardiol 45 2005 705 711
16. G.Y. Lip, L. Frison, and M. Grind Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation J Intern Med 261 2007 577 586
17. T. Van Noord, H.J.G.M. Crijns, M.P. van den Berg, D.J. Van Veldhuisen, and I.C. Van Gelder Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation BMC Cardiovasc Disord 5 2005 3
18. J.S. Healey, A. Baranchuk, E. Crystal, C.A. Morillo, M. Garfinkle, and S. Yusuf et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis J Am Coll Cardiol 45 2005 1832 1839
19. C.J. Boos, and G.Y. Lip Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials J Hum Hypertens 19 2005 855 859
20. H. Nakashima, K. Kumagai, H. Urata, N. Gondo, M. Ideishi, and K. Arakawa et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation Circulation 101 2000 2612 2617
21. A. Boldt, A. Scholl, J. Garbade, M.E. Resetar, F.W. Mohr, and J.F. Gummert et al. ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation Basic Res Cardiol 101 2006 261 267
22. Y. Li, W.-M. Li, Y.-T. Gong, B.-X. Li, W. Liu, and W. Han et al. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs Basic Res Cardiol 102 2007 245 256
23. D. Li, K. Shinagawa, L. Pang, T.K. Leung, S. Cardin, and Z. Wang et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure Circulation 104 2001 2608 2614